174 related articles for article (PubMed ID: 33054467)
1. Potential of microRNA based diagnostics and therapeutics in glioma: a patent review.
Mondal I; Kulshreshtha R
Expert Opin Ther Pat; 2021 Jan; 31(1):91-106. PubMed ID: 33054467
[TBL] [Abstract][Full Text] [Related]
2. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
3. Emerging patents in the therapeutic areas of glioma and glioblastoma.
Harris M; Svensson F; Kopanitsa L; Ladds G; Bailey D
Expert Opin Ther Pat; 2018 Jul; 28(7):573-590. PubMed ID: 29950117
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of glioma.
Marumoto T; Saya H
Adv Exp Med Biol; 2012; 746():2-11. PubMed ID: 22639155
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
6. Progress in the study of markers related to glioma prognosis.
Luo Y; Hou WT; Zeng L; Li ZP; Ge W; Yi C; Kang JP; Li WM; Wang F; Wu DB; Wang RY; Qu BL; Li XF; Wang JJ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7690-7697. PubMed ID: 32744695
[TBL] [Abstract][Full Text] [Related]
7. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
Li Y; Guessous F; Zhang Y; Dipierro C; Kefas B; Johnson E; Marcinkiewicz L; Jiang J; Yang Y; Schmittgen TD; Lopes B; Schiff D; Purow B; Abounader R
Cancer Res; 2009 Oct; 69(19):7569-76. PubMed ID: 19773441
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA targeting as a therapeutic strategy against glioma.
Auffinger B; Thaci B; Ahmed A; Ulasov I; Lesniak MS
Curr Mol Med; 2013 May; 13(4):535-42. PubMed ID: 22934848
[TBL] [Abstract][Full Text] [Related]
12. Circulating biomarkers for high-grade glioma.
Loo HK; Mathen P; Lee J; Camphausen K
Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
[No Abstract] [Full Text] [Related]
13. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
Ahir BK; Ozer H; Engelhard HH; Lakka SS
Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA is a biomarker for post-operative monitoring in glioma.
Morokoff A; Jones J; Nguyen H; Ma C; Lasocki A; Gaillard F; Bennett I; Luwor R; Stylli S; Paradiso L; Koldej R; Paldor I; Molania R; Speed TP; Webb A; Infusini G; Li J; Malpas C; Kalincik T; Drummond K; Siegal T; Kaye AH
J Neurooncol; 2020 Sep; 149(3):391-400. PubMed ID: 32915353
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA based theranostics for brain cancer: basic principles.
Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-342 inhibits the progression of glioma by directly targeting PAK4.
Lu X; Wang H; Su Z; Cai L; Li W
Oncol Rep; 2017 Aug; 38(2):1240-1250. PubMed ID: 28677773
[TBL] [Abstract][Full Text] [Related]
17. miRNA Multiplayers in glioma. From bench to bedside.
Rolle K
Acta Biochim Pol; 2015; 62(3):353-65. PubMed ID: 26307768
[TBL] [Abstract][Full Text] [Related]
18. A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells.
Esposito CL; Nuzzo S; Kumar SA; Rienzo A; Lawrence CL; Pallini R; Shaw L; Alder JE; Ricci-Vitiani L; Catuogno S; de Franciscis V
J Control Release; 2016 Sep; 238():43-57. PubMed ID: 27448441
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs as Potential Biomarkers in Glioma: A Mini-Review.
Choppavarapu L; Kandi SM
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):195-202. PubMed ID: 32744979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
